PMID-sentid	Pub_year	Sent_text	comp_official_name	comp_offset	protein_name	organism	prot_offset
34956484-0	2021	MiR-103a-3p aggravates renal cell carcinoma by targeting TMEM33.	mir-103a-3p	0-11	transmembrane protein 33	Homo sapiens	57-63
34956484-5	2021	A bioinformatics analysis and a dual-luciferase reporter gene assay revealed that there is a direct interaction between TMEM33 and miR-103a-3p.	mir-103a-3p	131-142	transmembrane protein 33	Homo sapiens	120-126
34956484-6	2021	Moreover, a rescue assay further confirmed that TMEM33 overexpression can attenuate miR-103a-3p-induced RCC cell development.	mir-103a-3p	84-95	transmembrane protein 33	Homo sapiens	48-54
34956484-7	2021	CONCLUSION: miR-103a-3p exerts a carcinogenic function in RCC by regulating TMEM33, a finding that may provide new insights into the development of prognostic markers and therapeutic targets for RCC.	mir-103a-3p	12-23	transmembrane protein 33	Homo sapiens	76-82
34642948-2	2021	A new study by Liu et al (2021) uncovers ER transmembrane protein TMEM33 as a novel target of PKM2, which is essential for regulation of cancer cell cholesterol metabolism.	Cholesterol	149-160	transmembrane protein 33	Homo sapiens	66-72